Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-01-05 | Cancer | ETA2023

Radioiodine therapy for thyroid cancer and dyfunction of the salivary and lachrymal glands in the start study: results at 6 months follow-up

Baudin Clemence , Bressand Alice , Buffet Camille , Menegaux Fabrice , Soret Marine , Broggio David , Bassinet Celine , Huet Christelle , Leenhardt Laurence , Bernier Marie-Odile , Lussey-Lepoutre Charlotte

Background: Understanding of changes in salivary and lachrymal gland functions after radioiodine therapy (131I-therapy) remains limited; and, to-date no studies have evaluated dose-response relationships between absorbed dose from 131I-therapy and dysfunctions of these glands. This study investigates salivary/lachrymal dysfunctions in differentiated thyroid cancer (DTC) patients six months after 131I-therapy, identifies 131I-therapy related risk ...